United States · FDA National Drug Code directory
VIMKUNYA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50632-018_cff3eb6b-993d-4dff-a6d8-64b03d33ee56
- Product NDC
- 50632-018
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- Chikungunya Vaccine, Recombinant
- Labeler
- Bavarian Nordic A/S
- Marketing category
- BLA
- Marketing start / end (source format)
- 20250301
- Source listing expiry
- 20271231
Source-listed ingredients
- CHIKUNGUNYA VIRUS SENEGAL STRAIN 37997 CAPSID PROTEIN — 10 ug/.8mL
- CHIKUNGUNYA VIRUS SENEGAL STRAIN 37997 ENVELOPE PROTEIN E1 — 15 ug/.8mL
- CHIKUNGUNYA VIRUS SENEGAL STRAIN 37997 ENVELOPE PROTEIN E2 — 15 ug/.8mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE, GLASS in 1 CARTON (50632-018-02) / .8 mL in 1 SYRINGE, GLASS (50632-018-04) · 50632-018-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →